Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$79000.0.

  • Rapid Micro Biosystems' Other Non Operating Income fell 10256.41% to -$79000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$211000.0, marking a year-over-year decrease of 9537.04%. This contributed to the annual value of -$112000.0 for FY2024, which is 3493.98% down from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Other Non Operating Income stood at -$79000.0, which was down 10256.41% from -$50000.0 recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Other Non Operating Income ranged from a high of $107000.0 in Q2 2022 and a low of -$3.1 million during Q3 2021
  • In the last 5 years, Rapid Micro Biosystems' Other Non Operating Income had a median value of -$22000.0 in 2022 and averaged -$190500.0.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 1732222.22% in 2021, then skyrocketed by 123750.0% in 2022.
  • Rapid Micro Biosystems' Other Non Operating Income (Quarter) stood at -$3.1 million in 2021, then soared by 99.65% to -$11000.0 in 2022, then crashed by 54.55% to -$17000.0 in 2023, then dropped by 23.53% to -$21000.0 in 2024, then plummeted by 276.19% to -$79000.0 in 2025.
  • Its last three reported values are -$79000.0 in Q3 2025, -$50000.0 for Q2 2025, and -$61000.0 during Q1 2025.